When it comes to medical research and advancement, we usually hear about the results of a successful study or a new drug in the latter stages of a clinical trial. Rarely does the media report on trials gone wrong or the unethical aspects of medical research. This is starting to change. A May 16 New York Times article, "Drug Trials Hide Conflicts for Doctors," presented a scathing view of the patient recruitment process, the result of a 10-month investigation. The report highlights the disturbing trend of pharmaceutical companies that offer doctors financial incentives to recruit patients in a timely fashion.
Clinical Trial Methods Attracting Closer Media Scrutiny of Patient Recruitment
You might also be interested in:
- Keep Your Boilerplates Fresh, Direct, Jargon-Free—If You're Still Using Them
- How Do Journalists Truly Feel About PR's Spray & Pray Approach? You May Not Like the Answer
- Volkswagen PR Exec Speaks: 'Company Takes This Matter Very Seriously,' Media Site Tab Added
- Week in PR
- PR News Data: PR Resists Lure of Live Streaming & Messaging Apps, Remains Cool on Paid Posts